| ||
| Amgen drug delays bone problems longer than Zometa Reuters O) new osteoporosis drug denosumab delayed fractures and other bone problems in patients with advanced breast cancer five months longer than Novartis AG's ... See all stories on this topic » | ||
| Syndax Pharma Study Offers Clues that Lung Cancer Treatment Could Benefit ... Xconomy Next year Syndax is expected to report data from a 125-patient mid-stage study of how well its drug improves treatment of advanced breast tumors in ... See all stories on this topic » | ||
| Another despicable abuse of a dead celebrity ScienceBlogs (blog) Well, when I wrote my post about the death of Elizabeth Edwards due to breast cancer two days ago, I wrote: I expect that it will not be long at all before ... See all stories on this topic » | ||
| Medical contract for 3D image firm The Northern Echo "We are looking forward to working with both Kromek and Nova towards a solution that could change the way breast cancer detection is carried out for many ... See all stories on this topic » | ||
| ||
| Drug combo helps women with early breast cancer Las Vegas Sun Evidence suggests it does not meaningfully improve survival for advanced cases. The new study tested it in more than 1900 women with early breast cancer or ... See all stories on this topic » | ||
| Lead-time in the European Randomised Study of Screening for Prostate Cancer ... UroToday Lead-time based on advanced prostate cancer only was slightly shorter, mean 5.3 years (95% CI 4.6-6.0). The lead-time for the second screening round was ... See all stories on this topic » |
| ||
| Denosumab Delayed Time to First Skeletal-related Side Effect ... By AACR Communication Staff These results detail an additional four months of blinded treatment. Stopeck and colleagues randomized 2046 patients with advanced breast cancer to receive either 120 mg of subcutaneous denosumab or 4 mg of intravenous zoledronic acid ... AACR News - http://aacrnews.wordpress.com/ | ||
| Epigenetic-molecular targeted therapy combination holds promise ... By admin Epigenetic-molecular targeted therapy combination holds promise against advanced lung cancer - Bio -A new study shows that a combination of epigenetic therapy and molecular targeted therapy has promising results at combating advanced ... Nektar Therapeutics today announced that new Phase 2 clinical data from its study of single-agent NKTR-102 in metastatic breast cancer patients will be presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium ( SABCS) in ... Biology and Medicine - http://enterprisepost.com/biomed/ | ||
| Drug combo helps women with early breast cancer - KTTC Rochester ... Evidence suggests it does not meaningfully improve survival for advanced cases. The new study tested it in more than 1900 women with early breast cancer or large tumors that are not the type that Herceptin or Tykerb can help. ... Tumors disappeared in nearly one in five women regardless of what treatment they got, said study leader Dr. Gunter von Minckwitz of the University of Frankfurt in Germany. One group did benefit: women with "triple negative" cancers - those not ... KTTC - National News - http://www.kttc.com/global/category.asp?c=13530 | ||
| Pertuzumab and Herceptin Plus Chemotherapy Significantly Improved ... Herceptin is approved for the treatment of early-stage breast cancer that is Human Epidermal growth factor Receptor 2-positive (HER2-positive) and has spread into the lymph nodes, or is HER2-positive and has not spread into the lymph ... Medical News - http://www.drugsfreelist.com/ | ||
| Breast lump, and is the disease??Axillary mass | Knowledge of disease By Japymyday breast cancer patients after middle age. Gradual increase in the incidence of breast cancer, and its onset of spring has the tendency of young, should take heed. Breast tumor is characterized by significant symptoms solitary nodular, hard texture, fluidity is poor, can not be pushed around, the border is not clear, irregular, and some tumor-like surface of the skin will be like tangerine peel rugged, In severe cases, into advanced breast cancer. Because of cancer invasion ... Knowledge of disease - http://www.sicheng.net/ | ||
| The Diagnosis of Lung Cancer - mesothelioma Once lung cancer has been diagnosed, the team of oncology physicians treating the patient will review the results to assess the treatment options for the lung cancer and to check whether any spread of the disease has occurred to other ... In the UK and North America, breast cancer is one of the most common forms of cancer that can affect women. Breast cancer amounts for 30% of female cancers in the UK and approximately 1 in 9 women in the UK will get breast cancer at some ... mesothelioma - http://www.mesothelioma123.tk/ | ||
| Amgen drug delays bone problems longer than Zometa | BinBon By michael LOS ANGELES, Dec 10 (Reuters) – Combining experimental antibody drug pertuzumab with Herceptin, an antibody first approved in 1998, and chemotherapy shrank tumors in nearly half of newly diagnosed breast cancer patients treated in a ... BinBon - http://www.binbon.com/ | ||
| Cancer Markers » Holidaymaker Section By BartNortonn Advanced cancer is indicated by higher tumor marker levels as well as prognosis is less constructive. With the help of cancer markers, a doctor can then determine the best treatment for your patient. Varieties of Cancer Markers ... If you have peculiar symptoms, breast changes, weight loss, uncommon bleeding, unexplained fatigue, gnawing pain, indigestion, changes in lymph nodes, depression, or persistent cough or sore that will not heal, go to see your doctor. ... Holidaymaker Section - http://kenoshagirlscouts.org/ |
| ||
| Syndax Pharmaceuticals' Entinostat in Combination Shows Activity ... Triple negative breast cancer (TNBC) is a sub-group of breast cancer that is ... studies: in advanced breast cancer in combination with aromatase inhibitors; ... HDACs are therefore recognized as promising targets for cancer treatment. ... www.earthtimes.org/.../shows-activity-breast-cancer,1580955... | ||
| Halaven - Discussion - Advanced Breast Cancer Support Community ... Advanced Breast Cancer Support Community · Advanced Breast Cancer Community ... My sister has just had her first treatment with Halaven (eribulinmesylate). ... www.inspire.com/groups/advanced-breast-cancer/.../halaven-1... | ||
| Amgen Presents New XGEVA(TM) (Denosumab) Breast Cancer Skeletal ... Breast Cancer Patients' Health-Related Quality of Life Improved When ... Zometa in the treatment of bone metastases in patients with advanced breast cancer ... www.cnbc.com/id/40610660 | ||
| CTRC-AACR 2010 SABCS Teleconferences and Podcasts The CTRC-AACR San Antonio Breast Cancer Symposium, Dec. 8-12, 2010, attracts world leaders in cancer research and treatment, including clinical ... of the first large nationwide study on the use of Taxol for advanced breast cancer, ... www.aacr.org/page23506.aspx | ||
| Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal ... Interim Results Demonstrate Skeletal-Related Events in Breast Cancer ... Zometa in the treatment of bone metastases in patients with advanced breast cancer ... seekingalpha.com/.../206917-amgen-presents-new-xgeva-den... | ||
| Treatment options for locally advanced breast cancer - experience ... Treatment options for locally advanced breast cancer - experience in an asian tertiary hospital. Chong HY, Taib NA, Rampal S, Saad M, Bustam AZ, Yip CH. ... www.ncbi.nlm.nih.gov/pubmed/21133600 | ||
| Health News - NICE says no to breast cancer drug Avastin ... bevacizumab (brand name Avastin) for use in patients with advanced breast cancer. ... Meg McArthur, senior policy officer at Breakthrough Breast Cancer, ... see more treatment options available for metastatic breast cancer patients. ... www.netdoctor.co.uk/.../news/theme_news_detail.php?id... | ||
| Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal ... Additional Data Shows Advanced Breast Cancer Patients Treated with XGEVA Experienced Less ..... Bone Drug Zometa Flops Overall As Breast Cancer Treatment ... pharmaceuticals.einnews.com/.../259519-amgen-presents-new-... | ||
| Breast Cancer Guide PR Newswire -- Randomized Phase II study shows 61% of advanced breast cancer patients on ... Bone Drug Zometa Flops Overall as Breast Cancer Treatment ... archive.wn.com/2010/12/10/1400/breastcancerguide/ | ||
| Syndax Pharmaceuticals' Entinostat in Combination Shows Activity ... HDACs are therefore recognized as promising targets for cancer treatment. .... for the treatment of patients with advanced (metastatic) breast cancer. ... pharma.daoblogs.com/8764.html | ||
| PubMed Result Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003370. Review. ... www.biology-direct.com/pubmed/related/16834778 | ||
| Future Medicine - Women's Health - 6(6):821 - Full Text The treatment for the majority of patients with advanced breast cancer is considered palliative in nature, although durable complete remissions have been ... www.futuremedicine.com/doi/abs/10.2217/whe.10.60 | ||
| Breast Cancer Metastasis – Latest Research, Treatment Options ... Doctors tell Elizabeth Edwards more cancer treatment would be unproductive ... for the treatment of patients with advanced (metastatic) breast cancer. ... www.breastcancermetastatic.com/.../boehringer-ingelheim-initi... |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment